Vallon, Volker
Thomson, Scott C.
Article History
First Online: 7 August 2017
Competing interests
: Over the past 36 months, V.V. has served as a consultant and received honoraria from Bayer, Boehringer Ingelheim, Intarcia Therapeutics, Astra-Zeneca, Janssen Pharmaceutical, Eli Lilly and Merck, and received grant support for investigator-initiated research from Astra-Zeneca, Bayer, Boehringer Ingelheim, Fresenius, and Janssen. Over the past 36 months, S.C.T. has received research support from Merck and Pfizer. These companies were not involved in the development or writing of this commentary.